Literature DB >> 27774909

Molecularly Engineered Polymer-Based Systems in Drug Delivery and Regenerative Medicine.

Susanna Piluso1, Al Halifa Soultan, Jennifer Patterson.   

Abstract

BACKGROUND: Polymer-based systems are attractive in drug delivery and regenerative medicine due to the possibility of tailoring their properties and functions to a specific application.
METHODS: The present review provides several examples of molecularly engineered polymer systems, including stimuli responsive polymers and supramolecular polymers.
RESULTS: The advent of controlled polymerization techniques has enabled the preparation of polymers with controlled molecular weight and well-defined architecture. By using these techniques coupled to orthogonal chemical modification reactions, polymers can be molecularly engineered to incorporate functional groups able to respond to small changes in the local environment or to a specific biological signal. This review highlights the properties and applications of stimuli-responsive systems and polymer therapeutics, such as polymer-drug conjugates, polymer-protein conjugates, polymersomes, and hyperbranched systems. The applications of polymeric membranes in regenerative medicine are also discussed.
CONCLUSION: The examples presented in this review suggest that the combination of membranes with polymers that are molecularly engineered to respond to specific biological functions could be relevant in the field of regenerative medicine. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  PEG; Stimuli-responsive polymers; drug delivery; hydrogels; hyperbranched polymers; polymer-protein conjugates; polymersomes; regenerative medicine

Mesh:

Substances:

Year:  2017        PMID: 27774909     DOI: 10.2174/1381612822666161021104239

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an in vitro study.

Authors:  Fábio Rocha Bohns; Vicente Castelo Branco Leitune; Isadora Martini Garcia; Bruna Genari; Nélio Bairros Dornelles; Silvia Stanisçuaski Guterres; Fabrício Aulo Ogliari; Mary Anne Sampaio de Melo; Fabrício Mezzomo Collares
Journal:  Restor Dent Endod       Date:  2020-10-07

Review 2.  Nanoparticle vaccines against respiratory syncytial virus.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Future Virol       Date:  2020-11-30       Impact factor: 1.831

Review 3.  Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19.

Authors:  Ferial Ghaemi; Amirhassan Amiri; Mohd Yazid Bajuri; Nor Yuliana Yuhana; Massimiliano Ferrara
Journal:  Sustain Cities Soc       Date:  2021-05-25       Impact factor: 7.587

Review 4.  Nanoparticle-Based Vaccines Against Respiratory Viruses.

Authors:  Soultan Al-Halifa; Laurie Gauthier; Dominic Arpin; Steve Bourgault; Denis Archambault
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 5.  Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms.

Authors:  Ameneh Jafari; Fahima Danesh Pouya; Zahra Niknam; Meghdad Abdollahpour-Alitappeh; Mostafa Rezaei-Tavirani; Yousef Rasmi
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

6.  ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy.

Authors:  Adilakshmi Boddu; Sreekanth Reddy Obireddy; Dahong Zhang; K S V Krishna Rao; Wing-Fu Lai
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 7.  Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.

Authors:  Rasha Itani; Mansour Tobaiqy; Achraf Al Faraj
Journal:  Theranostics       Date:  2020-05-01       Impact factor: 11.556

Review 8.  COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic.

Authors:  Valamla Bhavana; Pradip Thakor; Shashi Bala Singh; Neelesh Kumar Mehra
Journal:  Life Sci       Date:  2020-08-23       Impact factor: 5.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.